Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
- PMID: 35582568
- PMCID: PMC8992516
- DOI: 10.20517/cdr.2019.51
Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
Abstract
Ovarian cancer has a poor outcome because it is usually detected at advanced tumor stages, and the majority of the patients develop disease relapse as a result of chemotherapy resistance. This most lethal gynecological malignancy metastasizes within the peritoneal fluid or ascites to pelvic and distal organs. In ovarian cancer progression and metastasis, small non-coding RNAs (ncRNAs), including long noncoding RNAs and microRNAs have been recognized as important regulators. Their dysregulation modulates gene expression and cellular signal pathways and can be detected in liquid biopsies. In this review, we provide an overview on circulating plasma and serum ncRNAs participating in tumor cell migration and invasion, and contributing to recurrence and metastasis of ovarian cancer. We will also discuss the development of potential, novel therapies using ncRNAs as target molecules or tumor markers for ovarian cancer.
Keywords: Ovarian cancer recurrence; chemotherapy; epithelial-mesemchmal transition; metastasis; non-coding RNAs; tumor markers.
© The Author(s) 2019.
Conflict of interest statement
Both authors declared that there are no conflicts of interest.
Figures
Similar articles
-
Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.J Cancer. 2018 Apr 30;9(11):1966-1972. doi: 10.7150/jca.24550. eCollection 2018. J Cancer. 2018. PMID: 29896281 Free PMC article. Review.
-
Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118010. doi: 10.1177/17588359221118010. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35983027 Free PMC article. Review.
-
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.Front Oncol. 2023 Oct 3;13:1215194. doi: 10.3389/fonc.2023.1215194. eCollection 2023. Front Oncol. 2023. PMID: 37854681 Free PMC article. Review.
-
Dysregulation of non-coding RNAs in gastric cancer.World J Gastroenterol. 2015 Oct 21;21(39):10956-81. doi: 10.3748/wjg.v21.i39.10956. World J Gastroenterol. 2015. PMID: 26494954 Free PMC article. Review.
-
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.Front Genet. 2021 Aug 20;12:693259. doi: 10.3389/fgene.2021.693259. eCollection 2021. Front Genet. 2021. PMID: 34512721 Free PMC article. Review.
Cited by
-
Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.Noncoding RNA. 2024 Sep 30;10(5):51. doi: 10.3390/ncrna10050051. Noncoding RNA. 2024. PMID: 39452837 Free PMC article. Review.
-
Role of different non-coding RNAs as ovarian cancer biomarkers.J Ovarian Res. 2022 Jun 17;15(1):72. doi: 10.1186/s13048-022-01002-3. J Ovarian Res. 2022. PMID: 35715825 Free PMC article. Review.
-
Prognostic significance of non-coding RNAs related to the tumorigenic epithelial-mesenchymal transition (EMT) process among ovarian cancer patients: A systematic review and meta-analysis.Heliyon. 2024 Aug 8;10(16):e35202. doi: 10.1016/j.heliyon.2024.e35202. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253159 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources